A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens

Clinical trial NCT03092739 · COMPLETED

Trial details

NCT number: NCT03092739
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung Carcinoma, Small Cell

Start date: 2017-05-03
Primary completion: 2018-01-08
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.